arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

download Export Data

AETHLON MEDICAL INC

AEMD

$6.82 ▲ +0.16 (+2.33%) at close

17 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

AETHLON MEDICAL INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.6M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -149.3% ↘

FCF / Share $-10.39 ↘

Trailing P/E —

Price / Book 2.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-7.15M

↑ +46.6% —

Operating Margin Operating profit as % of sales

-494.6%

↓ -162.8% —

FCF / Share Free cash flow per share

$-10.39

↓ -112.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Revenue Growth YoY (%)	—	—	N/M	95.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1090%)	-55.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-792%)	1.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-83%)	183.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2189%)	53.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+568%)	-61.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-873%)	-55.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-797%)	16.3% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+104%)	-53.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-763%)	32.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+300%)	-9.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-219%)	—	—	—
EPS Growth YoY (%)	-23.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-76.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-723.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	16.9% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	46.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-9.7% Weak ↑ Weak Improving Year-over-year change in net income	-1.5% Weak ↑ Weak Improving Year-over-year change in net income	-15.5% Weak ↑ Weak Improving Year-over-year change in net income	-32.1% Weak ↓ Weak Declining Year-over-year change in net income	-23.7% Weak ↓ Weak Declining Year-over-year change in net income	-2.9% Weak ↑ Weak Improving Year-over-year change in net income	-9.1% Weak ↓ Weak Declining Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	-49.3% Weak ↓ Weak Declining Year-over-year change in net income	28.3% Excellent ↑ Excellent Improving Year-over-year change in net income	49.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-173.0% Weak ↓ Weak Declining Year-over-year change in net income	39.7% Excellent Excellent Year-over-year change in net income	-42.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-112.1% Weak ↑ Weak Improving Year-over-year change in free cash flow	-18.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	-641.1% Weak Weak Year-over-year change in free cash flow	18.7% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	18.1% Good Good Year-over-year change in free cash flow	22.3% Good Good Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	—	—	—	-4.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	8.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	63.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	18.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-36.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-41.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-37.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.3% Weak Weak Compound annual revenue growth over 3 years	-17.5% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	30.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-5.6% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-5.8% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-3.1% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-32.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-34.4% Weak Weak Compound annual revenue growth over 5 years	-22.0% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	-494.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3397%)	—	-188.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1355%)	-290.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2038%)	-229.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1627%)	—	—
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-397.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3414%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	-489.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-137.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-170.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-135.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Return on Invested Capital (%)	-149.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-144.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-173.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-66.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-195.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-712.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-223.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-512.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	16.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	30.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	26.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	60.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-115.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-126.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-153.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-145.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-65.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-353.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-173.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-289.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-180.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-719.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-371.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-803.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-146.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1076%)	-261.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1842%)	-211.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1511%)	-79.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-632%)	-60.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-505%)	-83.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-658%)	-67.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-552%)	-255.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1803%)	-92.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-717%)	—	—	—	89.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+496%)	53.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+257%)	87.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+482%)	95.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+537%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Interest Coverage (x)	—	-924.06x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-4993.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-109.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-27.21x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.04x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.83x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-51.02x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.82x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1.15x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-5.03M	$-5.50M	$-5.44M	$-14.53M	$-17.07M	$-9.86M	$-9.60M	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.03	$0.02	—	—	—	—	—	—	—	$0.01	$0.01	$0.01	—	—
Basic EPS, GAAP (USD)	$-10.61	$-8.58	$-4.86	$-0.59	$-0.71	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-10.39	$-4.90	$-4.13	$-0.56	$-0.69	—	—	—	—	—	—	—	$-0.01	$-0.01	$-0.02	—	—
Book Value per Share (USD)	$3.11	$2.55	$2.19	$0.66	$1.11	$0.78	$1.00	$1.91	$0.35	$0.08	$0.20	$0.09	$-0.07	$-0.05	$-0.08	$-0.08	—
Tangible Book Value per Share (USD)	$3.11	$2.55	$2.19	$0.66	$1.11	$0.78	$1.00	$1.91	$0.35	$0.08	$0.20	$0.09	$-0.07	$-0.05	$-0.08	$-0.08	—
Basic Weighted Avg Shares (shares)	673,945	1.56M	2.51M	20.54M	14.76M	—	—	—	—	—	—	—	194.06M	149.22M	101.77M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Working Capital (USD)	$4.12M	$4.05M	$4.40M	$13.59M	$16.33M	$8.98M	$8.97M	$2.21M	$6.75M	$985.50K	$1.85M	$630.42K	$-14.17M	$-9.28M	$-9.44M	$-6.13M	—
Total Equity (USD)	$4.89M	$5.12M	$5.77M	$15.06M	$17.13M	$9.43M	$9.41M	$2.43M	$6.13M	$676.38K	$1.55M	$615.45K	$-14.95M	$-9.14M	$-9.30M	$-5.98M	$-4.40M

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Mar 31, 2016 10-K ↗	FY 2015 Mar 31, 2015 10-K ↗	FY 2014 Mar 31, 2014 10-K ↗	FY 2013 Mar 31, 2013 10-K ↗	FY 2012 Mar 31, 2012 10-K ↗	FY 2011 Mar 31, 2011 10-K ↗	FY 2010 Mar 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$0.00	$574.25K	$294.17K	$659.10K	$650.19K	$229.62K	$149.62K	$392.07K	$886.57K	$762.42K	$1.62M	$1.23M	$1.36M	—	—
Depreciation Expense (USD)	$323.65K	$339.56K	$359.06K	$240.89K	$123.69K	$39.94K	$26.37K	$30.70K	$35.66K	$32.41K	$38.52K	$37.35K	$21.09K	$10.48K	$17.22K	$19.10K	—
Net Income, GAAP (USD)	$-7.15M	$-13.39M	$-12.21M	$-12.03M	$-10.42M	$-7.89M	$-6.37M	$-6.19M	$-5.68M	$-7.28M	$-4.87M	$-6.80M	$-13.36M	$-4.89M	$-8.11M	$-5.71M	—
Operating Cash Flow (USD)	$-7.00M	$-7.65M	$-10.13M	$-10.51M	$-9.77M	$-6.76M	$-5.20M	$-4.29M	$-3.91M	$-3.51M	$-4.33M	$-5.05M	$-2.14M	$-2.10M	$-1.84M	$-1.97M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 64 quarters

AETHLON MEDICAL INC

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AEMD with peers